PSMA PET/CT Detection of Chondromyxoid Fibroma. (5th June 2023)

• Record Type: Journal Article
• Authors: Jang, Albert; Caputo, Sydney A.; Hawkins, Madeline E.; Talbert, Joshua E.; Sartor, Oliver
• Is Part Of: Clinical nuclear medicine. Volume 48:Number 6(2023)
• Page Start: 545
• Page End: 546
• Publication Date: 2023-06-05
• Subjects: chondromyxoid fibroma -- 18F-DCFPyL prostate-specific membrane antigen -- prostate carcinoma; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000004649
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: A 61-year-old man underwent a piflufolastat 18 F prostate-specific membrane antigen (PSMA) PET/CT scan due to a rising prostate-specific antigen level. The scan noted a focal cortical erosion on the CT scan in the right anterolateral tibia, and the PET showed an SUVmax of 4.08. A biopsy of this lesion revealed a chondromyxoid fibroma. This rare case of a PSMA PET-positive chondromyxoid fibroma illustrates the importance of radiologists and oncologists not to assume an isolated bone lesion on a PSMA PET/CT scan as a bone metastasis from prostate cancer.